{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:05:32Z","timestamp":1768824332608,"version":"3.49.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1016\/j.cellimm.2008.06.003","type":"journal-article","created":{"date-parts":[[2008,7,16]],"date-time":"2008-07-16T20:02:09Z","timestamp":1216238529000},"page":"11-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Immune effects of mesenchymal stem cells: Implications for Charcot\u2013Marie\u2013Tooth disease"],"prefix":"10.1016","volume":"253","author":[{"given":"Alejandro","family":"Leal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Ichim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette M.","family":"Marleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Lara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalesh","family":"Kaushal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil H.","family":"Riordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2008.06.003_bib1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00007890-196803000-00009","article-title":"Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues","volume":"6","author":"Friedenstein","year":"1968","journal-title":"Transplantation"},{"key":"10.1016\/j.cellimm.2008.06.003_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2796.2007.01844.x","article-title":"Immunomodulation by mesenchymal stem cells and clinical experience","volume":"262","author":"Le Blanc","year":"2007","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cellimm.2008.06.003_bib3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1743-6109.2006.00114.x","article-title":"Stem cells isolated from adult rat muscle differentiate across all three dermal lineages","volume":"14","author":"Schultz","year":"2006","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.cellimm.2008.06.003_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1479-5876-5-57","article-title":"Endometrial regenerative cells: a novel stem cell population","volume":"5","author":"Meng","year":"2007","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cellimm.2008.06.003_bib5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/157488807782793763","article-title":"Mesenchymal stromal cells from umbilical cord blood","volume":"2","author":"Bieback","year":"2007","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.cellimm.2008.06.003_bib6","doi-asserted-by":"crossref","unstructured":"M. Liu, Z.C. Han, Mesenchymal stem cells: Biology and clinical potential in Type 1 Diabetes Therapy, J Cell Mol Med (2008).","DOI":"10.1111\/j.1582-4934.2008.00288.x"},{"key":"10.1016\/j.cellimm.2008.06.003_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/0022-3859.32215","article-title":"Adult mesenchymal stem cells: differentiation potential and therapeutic applications","volume":"53","author":"Jackson","year":"2007","journal-title":"J. Postgrad. Med."},{"key":"10.1016\/j.cellimm.2008.06.003_bib8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.moh.0000245697.54887.6f","article-title":"Mesenchymal stromal cells","volume":"13","author":"Keating","year":"2006","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.cellimm.2008.06.003_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/0470091452.ch5","article-title":"Multipotent adult progenitor cells: an update","volume":"265","author":"Verfaillie","year":"2005","journal-title":"Novartis Found Symp."},{"key":"10.1016\/j.cellimm.2008.06.003_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.20061115","article-title":"Hematopoietic reconstitution by multipotent adult progenitor cells: precursors to long-term hematopoietic stem cells","volume":"204","author":"Serafini","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2008.06.003_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.tp.0000267918.07906.08","article-title":"Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G","volume":"84","author":"Nasef","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.cellimm.2008.06.003_bib12","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2008.06.003_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-9255-2-8","article-title":"Mesenchymal stem cells avoid allogeneic rejection","volume":"2","author":"Ryan","year":"2005","journal-title":"J. Inflamm. (Lond)"},{"key":"10.1016\/j.cellimm.2008.06.003_bib14","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.4049\/jimmunol.179.3.1549","article-title":"Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density","volume":"179","author":"Romieu-Mourez","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2008.06.003_bib15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1634\/stemcells.2007-0554","article-title":"Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells","volume":"26","author":"Selmani","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.cellimm.2008.06.003_bib16","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/art.22511","article-title":"Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis","volume":"56","author":"Augello","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cellimm.2008.06.003_bib17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1089\/scd.2007.0065","article-title":"Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells","volume":"16","author":"Chen","year":"2007","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.cellimm.2008.06.003_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0966-3274(99)80035-5","article-title":"Induction of negative regulators of haematopoiesis in human bone marrow cells by HLA-DR cross-linking","volume":"7","author":"Yamaguchi","year":"1999","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.cellimm.2008.06.003_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/sj.leu.2401250","article-title":"Role of TNF alpha in bryostatin-induced inhibition of human hematopoiesis","volume":"13","author":"Drager","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.cellimm.2008.06.003_bib20","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1182\/blood.V86.9.3373.bloodjournal8693373","article-title":"Hematopoietic inhibition by interferon-gamma is partially mediated through interferon regulatory factor-1","volume":"86","author":"Sato","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2008.06.003_bib21","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1182\/blood-2006-12-061713","article-title":"Homeostatic expansion and repertoire regeneration of donor T cells during graft versus host disease is constrained by the host environment","volume":"109","author":"Gorski","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2008.06.003_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbmt.2005.10.023","article-title":"Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report","volume":"12","author":"Shulman","year":"2006","journal-title":"Biol. Blood Marrow Transplant"},{"key":"10.1016\/j.cellimm.2008.06.003_bib23","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.cellimm.2008.06.003_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jcp.20959","article-title":"From the laboratory bench to the patient\u2019s bedside: an update on clinical trials with mesenchymal stem cells","volume":"211","author":"Giordano","year":"2007","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.cellimm.2008.06.003_bib25","first-page":"473","article-title":"OTI-010 Osiris Therapeutics\/JCR Pharmaceuticals","volume":"7","author":"Taupin","year":"2006","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.cellimm.2008.06.003_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1517\/14712598.6.1.17","article-title":"Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection","volume":"6","author":"Uccelli","year":"2006","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.cellimm.2008.06.003_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00403-007-0827-9","article-title":"Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model","volume":"300","author":"Sbano","year":"2008","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.cellimm.2008.06.003_bib28","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1016\/j.transproceed.2007.06.092","article-title":"Mesenchymal stem cells modulate immune responses combined with cyclosporine in a rat renal transplantation model","volume":"39","author":"Zhang","year":"2007","journal-title":"Transplant Proc."},{"key":"10.1016\/j.cellimm.2008.06.003_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.yjmcc.2006.10.003","article-title":"Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis","volume":"42","author":"Ohnishi","year":"2007","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.cellimm.2008.06.003_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jns.2005.11.015","article-title":"Peripheral neuropathies caused by mutations in the myelin protein zero","volume":"242","author":"Shy","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cellimm.2008.06.003_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1529-8027.2002.02001.x","article-title":"Recent progress on the molecular organization of myelinated axons","volume":"7","author":"Scherer","year":"2002","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.cellimm.2008.06.003_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng0993-31","article-title":"Charcot\u2013Marie\u2013Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene","volume":"5","author":"Hayasaka","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellimm.2008.06.003_bib33","first-page":"6","article-title":"Mutations in the myelin protein zero result in a spectrum of Charcot\u2013Marie\u2013Tooth phenotypes","volume":"23","author":"Kochanski","year":"2004","journal-title":"Acta Myol."},{"key":"10.1016\/j.cellimm.2008.06.003_bib34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0092-8674(92)90591-Y","article-title":"Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons","volume":"71","author":"Giese","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.cellimm.2008.06.003_bib35","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1073\/pnas.97.11.6126","article-title":"Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation","volume":"97","author":"Liu","year":"2000","journal-title":"Proc. Natl. Acad Sci. USA"},{"key":"10.1016\/j.cellimm.2008.06.003_bib36","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/glia.20534","article-title":"A mouse embryonic stem cell model of Schwann cell differentiation for studies of the role of neurofibromatosis type 1 in Schwann cell development and tumor formation","volume":"55","author":"Roth","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.cellimm.2008.06.003_bib37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1634\/stemcells.22-4-448","article-title":"Human embryonic stem cells possess immune-privileged properties","volume":"22","author":"Li","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.cellimm.2008.06.003_bib38","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1096\/fj.06-6769com","article-title":"Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response","volume":"21","author":"Nussbaum","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.cellimm.2008.06.003_bib39","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1634\/stemcells.2007-0212","article-title":"Specification of a dopaminergic phenotype from adult human mesenchymal stem cells","volume":"25","author":"Trzaska","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.cellimm.2008.06.003_bib40","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2217\/17460751.2.5.817","article-title":"Cellular approaches for stimulating CNS remyelination","volume":"2","author":"Miller","year":"2007","journal-title":"Regen. Med."},{"key":"10.1016\/j.cellimm.2008.06.003_bib41","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/glia.20421","article-title":"Phenotypic and functional characteristics of mesenchymal stem cells differentiated along a Schwann cell lineage","volume":"54","author":"Caddick","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.cellimm.2008.06.003_bib42","first-page":"326","article-title":"Study on the adoption of Schwann cell phenotype by bone marrow stromal cells in vitro and in vivo","volume":"18","author":"Zhao","year":"2005","journal-title":"Biomed. Environ. Sci."},{"key":"10.1016\/j.cellimm.2008.06.003_bib43","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1081\/BIO-200039608","article-title":"Bone marrow stromal cells differentiated into functional Schwann cells in injured rats sciatic nerve","volume":"32","author":"Zhang","year":"2004","journal-title":"Artif. Cells Blood Substit. Immobil. Biotechnol."},{"key":"10.1016\/j.cellimm.2008.06.003_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1389450053345000","article-title":"Stem cell therapy for myelin diseases","volume":"6","author":"Ben-Hur","year":"2005","journal-title":"Curr. Drug. Targets."},{"key":"10.1016\/j.cellimm.2008.06.003_bib45","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00005072-199806000-00009","article-title":"Fate of Schwann cells in CMT1A and HNPP: evidence for apoptosis","volume":"57","author":"Erdem","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.cellimm.2008.06.003_bib46","doi-asserted-by":"crossref","first-page":"R880","DOI":"10.1152\/ajpregu.00280.2006","article-title":"Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism","volume":"291","author":"Wang","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.cellimm.2008.06.003_bib47","first-page":"31","article-title":"The neuroprotective function of vascular endothelial growth factor (VEGF)","volume":"43","author":"Gora-Kupilas","year":"2005","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.cellimm.2008.06.003_bib48","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1167\/iovs.04-0455","article-title":"Neuroprotective effect of hepatocyte growth factor against photoreceptor degeneration in rats","volume":"45","author":"Machida","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.cellimm.2008.06.003_bib49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1006\/viro.2002.1690","article-title":"Neuroprotective effects of IGF-I against TNFalpha-induced neuronal damage in HIV-associated dementia","volume":"305","author":"Ying Wang","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.cellimm.2008.06.003_bib50","first-page":"1035","article-title":"Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury","volume":"14","author":"Herrera","year":"2004","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cellimm.2008.06.003_bib51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/scd.2006.0089","article-title":"Intravenous delivery of autologous mesenchymal stem cells limits infarct size and improves left ventricular function in the infarcted porcine heart","volume":"16","author":"Krause","year":"2007","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.cellimm.2008.06.003_bib52","doi-asserted-by":"crossref","first-page":"H2670","DOI":"10.1152\/ajpheart.01071.2003","article-title":"Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis","volume":"287","author":"Nagaya","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cellimm.2008.06.003_bib53","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0079-6123(06)61026-1","article-title":"In vivo tracking of stem cells in brain and spinal cord injury","volume":"161","author":"Sykova","year":"2007","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.cellimm.2008.06.003_bib54","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/sj.bmt.1705757","article-title":"Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury","volume":"40","author":"Parr","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.cellimm.2008.06.003_bib55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/jir.2006.0037","article-title":"Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone","volume":"27","author":"Croitoru-Lamoury","year":"2007","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.cellimm.2008.06.003_bib56","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/sj.ki.5002334","article-title":"Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury","volume":"72","author":"Herrera","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellimm.2008.06.003_bib57","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<474::AID-MUS8>3.0.CO;2-9","article-title":"Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy","volume":"19","author":"Schmidt","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cellimm.2008.06.003_bib58","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0165-0173(01)00097-2","article-title":"Disease mechanisms and potential therapeutic strategies in Charcot\u2013Marie\u2013Tooth disease","volume":"36","author":"Young","year":"2001","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.cellimm.2008.06.003_bib59","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00005072-199756070-00008","article-title":"Heterozygous P0 knockout mice develop a peripheral neuropathy that resembles chronic inflammatory demyelinating polyneuropathy (CIDP)","volume":"56","author":"Shy","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.cellimm.2008.06.003_bib60","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1469-7580.2002.00045.x","article-title":"Role of immune cells in animal models for inherited neuropathies: facts and visions","volume":"200","author":"Maurer","year":"2002","journal-title":"J. Anat."},{"key":"10.1016\/j.cellimm.2008.06.003_bib61","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.mcn.2005.12.007","article-title":"Attenuated demyelination in the absence of the macrophage-restricted adhesion molecule sialoadhesin (Siglec-1) in mice heterozygously deficient in P0","volume":"31","author":"Kobsar","year":"2006","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.cellimm.2008.06.003_bib62","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1385\/NMM:8:1-2:175","article-title":"Role of immune cells in animal models for inherited peripheral neuropathies","volume":"8","author":"Wang Ip","year":"2006","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.cellimm.2008.06.003_bib63","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/jnr.20601","article-title":"Evidence for macrophage-mediated myelin disruption in an animal model for Charcot\u2013Marie\u2013Tooth neuropathy type 1A","volume":"81","author":"Kobsar","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.cellimm.2008.06.003_bib64","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1212\/WNL.41.3.437","article-title":"Corticosteroid-responsive dominantly inherited neuropathy in childhood","volume":"41","author":"Bird","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.cellimm.2008.06.003_bib65","first-page":"239","article-title":"Prednisone-responsive hereditary motor and sensory neuropathy","volume":"57","author":"Dyck","year":"1982","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.cellimm.2008.06.003_bib66","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.carpath.2006.04.006","article-title":"C-reactive protein: a nontraditional serum marker of cardiovascular risk","volume":"16","author":"de Ferranti","year":"2007","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.cellimm.2008.06.003_bib67","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/1097-4547(20000615)60:6<714::AID-JNR3>3.0.CO;2-1","article-title":"Absence of P0 leads to the dysregulation of myelin gene expression and myelin morphogenesis","volume":"60","author":"Xu","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.cellimm.2008.06.003_bib68","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.cellbio.23.090506.123337","article-title":"Hyaluronan in tissue injury and repair","volume":"23","author":"Jiang","year":"2007","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.cellimm.2008.06.003_bib69","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nm1279","article-title":"Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation","volume":"11","author":"Back","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2008.06.003_bib70","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/mcne.1996.0035","article-title":"TNF alpha inhibits Schwann cell proliferation, connexin46 expression, and gap junctional communication","volume":"7","author":"Chandross","year":"1996","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.cellimm.2008.06.003_bib71","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.clpt.6100386","article-title":"Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy","volume":"83","author":"Lee","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cellimm.2008.06.003_bib72","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ana.20501","article-title":"Autologous mesenchymal stem cell transplantation in stroke patients","volume":"57","author":"Bang","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cellimm.2008.06.003_bib73","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1089\/scd.2006.15.349","article-title":"Ex vivo expansion and in vivo infusion of bone marrow-derived Flk-1+CD34- mesenchymal stem cells: feasibility and safety from monkey to human","volume":"15","author":"Liu","year":"2006","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.cellimm.2008.06.003_bib74","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1634\/stemcells.2007-0226","article-title":"Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis","volume":"25","author":"Wu","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.cellimm.2008.06.003_bib75","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1212\/01.WNL.0000171978.70849.c5","article-title":"NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients","volume":"65","author":"Sahenk","year":"2005","journal-title":"Neurology"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874908001093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874908001093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:42:28Z","timestamp":1757803348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874908001093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":75,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008]]}},"alternative-id":["S0008874908001093"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2008.06.003","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune effects of mesenchymal stem cells: Implications for Charcot\u2013Marie\u2013Tooth disease","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2008.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}